Literature DB >> 4693581

Chlorambucil vs. combined chlorambucil-corticosteroid therapy in chronic lymphocytic leukemia.

T Han, E Z Ezdinli, K Shimaoka, D V Desai.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1973        PMID： 4693581     DOI： 10.1002/1097-0142(197303)31:3<502::aid-cncr2820310303>3.0.co;2-7

Source DB:  PubMed          Journal:  Cancer        ISSN： 0008-543X            Impact factor:   6.860


× No keyword cloud information.
  17 in total

1.  Outcome of advanced chronic lymphocytic leukemia following different first-line and relapse therapies: a meta-analysis of five prospective trials by the German CLL Study Group (GCLLSG).

Authors:  Paula Cramer; Susanne Isfort; Jasmin Bahlo; Stephan Stilgenbauer; Hartmut Döhner; Manuela Bergmann; Martina Stauch; Michael Kneba; Elisabeth Lange; Petra Langerbeins; Natali Pflug; Gabor Kovacs; Valentin Goede; Anna-Maria Fink; Thomas Elter; Kirsten Fischer; Clemens-Martin Wendtner; Michael Hallek; Barbara Eichhorst
Journal:  Haematologica       Date:  2015-08-27       Impact factor: 9.941

2.  Combination chemoimmunotherapy with pentostatin, cyclophosphamide, and rituximab shows significant clinical activity with low accompanying toxicity in previously untreated B chronic lymphocytic leukemia.

Authors:  Neil E Kay; Susan M Geyer; Timothy G Call; Tait D Shanafelt; Clive S Zent; Diane F Jelinek; Renee Tschumper; Nancy D Bone; Gordon W Dewald; Thomas S Lin; Nyla A Heerema; Lisa Smith; Michael R Grever; John C Byrd
Journal:  Blood       Date:  2006-09-28       Impact factor: 22.113

Review 3.  [Chronic lymphatic leukemia and hairy cell leukemia. Diagnosis and therapy].

Authors:  G Brittinger; K P Hellriegel; W Hiddemann
Journal:  Med Klin (Munich)       Date:  1997-06-15

Review 4.  On the architecture of translational research designed to control chronic lymphocytic leukemia.

Authors:  Michael Hallek
Journal:  Hematology Am Soc Hematol Educ Program       Date:  2018-11-30

Review 5.  Management of chronic lymphocytic leukaemia.

Authors:  N Kalil; B D Cheson
Journal:  Drugs Aging       Date:  2000-01       Impact factor: 3.923

6.  Repeated pentostatin (2'deoxycoformycin)-induced remissions in a patient with advanced chronic lymphocytic leukemia.

Authors:  R O Dillman; A L Yu; C N Qiao
Journal:  West J Med       Date:  1988-03

7.  Principles and present status of a prospective multicenter study on the clinical relevance of the Kiel classification.

Authors:  G Brittinger; U Schmalhorst; H Bartels; H H Fülle; H Gerhartz; G Gremmel; T Grisar; H J Grupp; U Gunzer; D Huhn; K M Koeppen; B Kubanek; H Leopold; H Löffler; G W Löhr; L Nowicki; U Rühl; M Schmidt; A Stacher; H Theml; K Lennert
Journal:  Blut       Date:  1981-09

8.  Diagnostic and therapeutic problems in non-Hodgkin lymphomas.

Authors:  K Musshoff; H Brücher
Journal:  Blut       Date:  1981-09

Review 9.  Update on chronic lymphocytic leukemia: overview of new agents and comparative analysis.

Authors:  Sanford Kempin
Journal:  Curr Treat Options Oncol       Date:  2013-06

10.  Effect of first-line treatment on second primary malignancies and Richter's transformation in patients with CLL.

Authors:  C Maurer; P Langerbeins; J Bahlo; P Cramer; A M Fink; N Pflug; A Engelke; J von Tresckow; G Kovacs; S Stilgenbauer; C-M Wendtner; L Müller; M Ritgen; T Seiler; K Fischer; M Hallek; B Eichhorst
Journal:  Leukemia       Date:  2016-05-02       Impact factor: 11.528
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.